$INGR

Diego Reynoso named Ingredion EVP & CFO as Jason Payant returns to VP Finance role

Ingredion Inc. (INGR) appointed Diego Reynoso as EVP and CFO, replacing Jason Payant, who returns to VP Finance. Reynoso previously served as CFO at The Boston Beer Company (SAM) and held senior roles at Tyson Foods (TSN), Constellation Brands (STZ), and Beam Suntory.

Original reporting
Published Aug 20, 2026, 8:23 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 21, 2026, 7:01 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Diego Reynoso named Ingredion EVP & CFO as Jason Payant returns to VP Finance role — source image
Decision brief

The 30-second read

$INGRNeutralMed
01

Why it matters

The appointment could influence future capital allocation and earnings guidance.

02

Market read

Executive change news for a mid‑cap consumer staples company; modest trading relevance.

03

What to watch

Reynoso's prior experience at Boston Beer and Tyson may bring cross‑industry insights.

Relevance 6/10Novelty 6/10Timing: today

Background

Ingredion announced a senior finance leadership reshuffle, naming Diego Reynoso as EVP & CFO.

Company-level read

Ticker impact

$INGRNeutralMedium confidence
Context

Diego Reynoso appointed EVP & CFO of Ingredion, replacing Jason Payant who moves to VP Finance.

Expected impact

Potential modest upside if market views the hire positively.

Evidence & confidence

Executive changes are material but typically have limited immediate price impact.

Market effects

May signal Ingredion's focus on finance and growth initiatives within the food ingredients sector.

Limited to US-listed consumer staples investors.

Low global impact beyond Ingredion shareholders.

Counterpoint

The CFO change could be a distraction and may not translate into operational improvements.

Key entities

  • Diego Reynoso

    New EVP & CFO of Ingredion.

  • Jason Payant

    Moves to VP Finance role at Ingredion.

Related articles

$INGRMed

Ingredion (INGR), Why Is It Back In The Spotlight?

Ingredion (INGR) appointed Diego Reynoso as CFO, effective October 1, 2026. The company's share price is $104.62, with mixed recent returns. Analysts have differing views on its valuation, with AgWiz estimating it as 18.6% overvalued at a fair value of $88.23, while another DCF model values it at $222.82. The company's future performance depends on its integration of Tate & Lyle and shift to specialty ingredients.

$INGRMedAI 8/10

Ingredion's carrot fibre wins EU approval

Ingredion received EU approval for Benicaros SF Pure P, a carrot fibre, allowing its sale in the EU from July 2026. The fibre is plant-based, low-dose, and designed for use in foods, beverages, and supplements without affecting taste or texture. Ingredion acquired Benicaros in June 2026, positioning the ingredient as part of its focus on science-backed nutrition. The EU approval could boost adoption among European formulators.

$DARMedAI 8/10

A Look Back at Ingredients, Flavors & Fragrances Stocks’ Q2 Earnings: Darling Ingredients (NYSE:DAR) Vs The Rest Of The Pack

Ingredients, flavors, and fragrances stocks reported mixed Q2 earnings, with revenues missing estimates by 2.4%. Darling Ingredients (DAR) reported $1.72B revenue, up 16.4% YoY, beating estimates. Archer-Daniels-Midland (ADM) reported $22.68B revenue, up 7.2% YoY, outperforming estimates. International Flavors & Fragrances (IFF) reported $1.95B revenue, down 29.3% YoY, missing estimates. Ingredion (INGR) reported $1.85B revenue, flat YoY, topping estimates. Bunge Global (BG) reported $24.04B rev

$INGRMedAI 8/10

Ingredion (INGR) Q2 2026 Earnings Call Transcript

Ingredion (NYSE:INGR) reported Q2 2026 net sales of $1.85B (+1%) and adjusted operating income of $258M (-5%). Adjusted EPS was $2.82. Management cited Argo facility issues, Mexico currency headwinds, and rising tapioca costs. It reaffirmed 2026 adjusted EPS guidance of $10.30 to $10.90 and expects Tate & Lyle acquisition synergies of $130M run-rate by 2030.